Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Allmed (Pvt.) Ltd

Healthcare and pharmaceutical company · Lahore · Pakistan

Karachi healthcare group active in pharmaceuticals, medical equipment and diagnostics, with a specialized renal-care pharmaceutical portfolio.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date20 Aug 2026Newest effective date among published current price records
Corporate profile evidence6 sourcesCorporate source details checked 21 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Allmed (Pvt.) Ltd.
Company type
Healthcare and pharmaceutical company
Address
Plot No. 590, Sundar Industrial Estate, Lahore, Pakistan · 74800
Phone
+92 21 34943800
Official contact
Contact page ↗
Corporate source details checked
21 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000645 Allmed (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000645 82 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger City source ↗ Contact Page Url source ↗ Logo Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx82public portfolio records represented
REG75unique registrations represented
IDX43indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR73current validated price records
G48generic molecules in indexed catalogue
DF8dosage-form groups
TA10therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage89%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage98%
priced packs safely normalized per unit
Comparable-market coverage84%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixAllmed (Pvt.) LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/allmed-pvt-ltdGenerated 23 Sep 2026Anti-infectives43 · 52%Vitamins, minerals & nutrition9 · 11%Respiratory & allergy8 · 10%Gastrointestinal & hepatology6 · 7%Pain & musculoskeletal5 · 6%Hematology & thrombosis3 · 4%Fluids & supportive care2 · 2%Other therapeutic areas6 · 7%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioAllmed (Pvt.) LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/allmed-pvt-ltdGenerated 23 Sep 202682presentationsTablet39 · 48%Capsule11 · 13%Injection10 · 12%Syrup10 · 12%Infusion8 · 10%Inhalation2 · 2%Other forms2 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionAllmed (Pvt.) LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/allmed-pvt-ltdGenerated 23 Sep 202669comparable productsBelow peer median20 · 29%Near peer median21 · 30%Above peer median28 · 41%Company median price position+2.8%Lowest-price equivalents6Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsAllmed (Pvt.) LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/allmed-pvt-ltdGenerated 23 Sep 2026Mediate Pharmaceutical Pvt Ltd29 shared60% overlapSAMI Pharmaceuticals Pvt. Ltd.29 shared60% overlapEpharm Laboratories29 shared60% overlapBosch Pharmaceuticals (Pvt) Ltd.28 shared58% overlapGlitz Pharma28 shared58% overlapNabiqasim Industries (Pvt) Ltd.,27 shared56% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives43 products · 52%
Vitamins, minerals & nutrition9 products · 11%
Respiratory & allergy8 products · 10%
Gastrointestinal & hepatology6 products · 7%
Pain & musculoskeletal5 products · 6%
Hematology & thrombosis3 products · 4%
Fluids & supportive care2 products · 2%
Anesthesia & critical care2 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Fluoroquinolone antibacterials12 products · 15%
Vitamins / minerals / hematinics9 products · 11%
Antimalarials9 products · 11%
Antivirals6 products · 7%
Analgesics / NSAIDs5 products · 6%
Third-generation cephalosporins5 products · 6%
Macrolide antibacterials4 products · 5%
Antihistamines4 products · 5%
Formulation footprint

Dosage forms

Tablet39 products
Capsule11 products
Injection10 products
Syrup10 products
Infusion8 products
Inhalation2 products
Solution1 products
Suspension1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 A-CIPCiprofloxacin 4presentations 200 mg/100 mL, 250 mg, 400 mg/100 mL, 500 mg · Infusion, Tablet #2 LEVOGREENLevofloxacin 4presentations 250 mg, 250 mg/100 mL, 500 mg, 500 mg/100 mL · Tablet, Infusion #3 SALBUGREENSalbutamol 4presentations 0.5 mg/mL, 2 mg, 2 mg/5 mL, 4 mg · Injection, Tablet, Syrup #4 ANOMEDOndansetron 3presentations 4 mg/5 mL, 8 mg · Solution, Tablet, Injection #5 EverpolParacetamol 3presentations 1 g/100 mL, 500 mg · Infusion, Tablet #6 IvoryzoneCeftriaxone 3presentations 1 g, 250 mg, 500 mg · Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median2029% of comparable products
Near market median21within ±5% of median
Above market median2841% of comparable products
Lowest-price equivalents6ties included
Company median price position +2.8% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
LEVOGREEN 250 mgLevofloxacin · Tablet · 10'S PKR 20.65/tablet-57.2% vs market median LEVOGREEN 500 mgLevofloxacin · Tablet · 10'S PKR 41.30/tablet-47.8% vs market median ITRDYM 100 mgItraconazole · Capsule · 4'S PKR 89.76/capsule-38.4% vs market median DIREARID 2 mgLoperamide HCl · Capsule · 20'S PKR 3.34/capsule-35.5% vs market median B-FIX 100 mgLamivudine · Tablet · 14's PKR 41.31/tablet-27.5% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 29shared generics SAMI Pharmaceuticals Pvt. Ltd.194 products · 63 generics 29shared generics Epharm Laboratories144 products · 67 generics 29shared generics Bosch Pharmaceuticals (Pvt) Ltd.258 products · 74 generics 28shared generics Glitz Pharma170 products · 73 generics 28shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 27shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers75Distinct registrations among indexed, published, presentation-validated products only
Verified price observations153
Products with a verified price82
Products with multiple price observations71
Source records with multiple versions82
Latest portfolio source check22 Sep 2026
Latest effective price date20 Aug 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

75 unique registration(s) · 43 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Intelligence filter: Therapeutic areaAnti-infectives Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
A-CIP Ciprofloxacin 500 mg Tablet 10'S 052426 PKR 444.03 PKR 44.40/tablet Near median
A-CIP Ciprofloxacin 250 mg Tablet 10'S 052428 PKR 268.49 PKR 26.85/tablet 6% above median
A-CIP Ciprofloxacin 200 mg/100 mL IV infusion 1'S 062617 PKR 247.84 PKR 247.84/vial/unit 20% above median
A-CIP Ciprofloxacin 400 mg/100 mL IV infusion 1'S 062623 PKR 340.78 PKR 340.78/vial/unit Near median
B-FIX Lamivudine 100 mg Tablet 14's 054399 PKR 578.27 PKR 41.31/tablet 28% below median
C-TX Valganciclovir 450 mg Tablet 60's 105652 PKR 130,361.68 PKR 2,172.69/tablet Near median
CLAMY-250 Clarithromycin 250 mg Tablet 10'S 052421 PKR 495.66 PKR 49.57/tablet Near median
CLAMY-500 Clarithromycin 500 mg Tablet 10'S 052419 PKR 826.11 PKR 82.61/tablet Near median
Dymzol Clotrimazole 500 mg Tablet 1'S 052431 PKR 132.18 PKR 132.18/tablet 9% above median
FOFY Fosfomycin 500 mg Capsule 10'S 052446 PKR 223.17 PKR 22.32/capsule 52% above median
ITRDYM Itraconazole 100 mg Capsule 4'S 052444 PKR 359.04 PKR 89.76/capsule 38% below median
Ivoryzone Ceftriaxone 1 g Injection 1'S 045001 PKR 662.95 PKR 662.95/vial/unit 10% above median
IVORYZONE Ceftriaxone 500 mg Injection 1'S 045002 PKR 351.09 PKR 351.09/vial/unit 8% above median
Ivoryzone Ceftriaxone 250 mg Injection 1'S 045003 PKR 208.60 PKR 208.60/vial/unit 9% above median
IZITHOL Azithromycin 250 mg Capsule 10'S 052450 PKR 398.92 PKR 39.89/capsule 19% below median
IZITHOL Azithromycin 500 mg Tablet 6's 104640 PKR 412.68 PKR 68.78/tablet 19% below median
LEVOGREEN Levofloxacin 500 mg Tablet 10'S 052425 PKR 413.04 PKR 41.30/tablet 48% below median
LEVOGREEN Levofloxacin 250 mg Tablet 10'S 052427 PKR 206.53 PKR 20.65/tablet 57% below median
LEVOGREEN Levofloxacin 500 mg/100 mL IV infusion 1'S 062618 PKR 671.27 PKR 671.27/vial/unit 35% above median
LEVOGREEN Levofloxacin 250 mg/100 mL IV infusion 1'S 062619 PKR 671.27 PKR 671.27/vial/unit No comparator
LOMAR Artemether + Lumefantrine 40 mg + 240 mg Tablet 8'S 054391 PKR 545.23 PKR 68.15/tablet 6% above median
LOMAR Artemether + Lumefantrine 20 mg + 120 mg Tablet 16'S 054408 PKR 660.88 PKR 41.31/tablet 5% above median
LOMAR Artemether 80 mg/mL Injection 6'S 067901 PKR 823.93 PKR 137.32/vial/unit 26% below median
LORITA Lopinavir + Ritonavir 200 mg + 50 mg Tablet 120's 102315 PKR 11,525.21 PKR 96.04/tablet Near median
Maxon Moxifloxacin 400 mg Tablet 5'S 052420 PKR 947.47 PKR 189.49/tablet Near median
Maxon Moxifloxacin 400 mg/250 mL IV infusion 1'S 062620 PKR 2,161.07 PKR 2,161.07/vial/unit 5% below median
METLA Metronidazole 400 mg Tablet 100'S 052432 PKR 388.11 PKR 3.88/tablet 31% above median
METLA Metronidazole 200 mg/5 mL Syrup 60ML 052456 PKR 67.44 PKR 1.12/mL No comparator
METLA Metronidazole 500 mg/100 mL IV infusion 1'S 062622 PKR 161.09 PKR 161.09/vial/unit 10% above median
OKSIN Ofloxacin 200 mg Tablet 10'S 052424 PKR 206.53 PKR 20.65/tablet 10% below median
OKSIN Ofloxacin 200 mg/100 mL IV infusion 1'S 062621 PKR 309.78 PKR 309.78/vial/unit 35% above median
QUINGEN Chloroquine 250 mg Tablet 500's 102313 PKR 682.72 PKR 1.37/tablet 13% below median
QUINGEN Chloroquine 50 mg/5 mL Syrup 60ml 102314 PKR 21.22 PKR 0.35/mL 6% above median
QUINGEN-H Hydroxychloroquine 200 mg Tablet 50’s 102312 PKR 675.31 PKR 13.51/tablet 7% below median
QUINGEN-H Hydroxychloroquine 200 mg Tablet 30’s 102312 PKR 405.18 PKR 13.51/tablet 7% below median
RUTEX Cefixime 100 mg/5 mL Suspension 30 ML 045013 PKR 330.39 PKR 11.01/mL Near median
RUTEX Cefixime 400 mg Capsule 5'S 045014 PKR 592.03 PKR 118.41/capsule Near median
TAMAVIR Oseltamivir 75 mg Capsule 10's 102316 PKR 1,125.51 PKR 112.55/capsule 7% below median
VIRLIL Ribavirin 400 mg Capsule 10'S 052445 PKR 619.58 PKR 61.96/capsule 8% above median
VIRLIL Ribavirin 600 mg Tablet 10'S 054400 PKR 1,569.61 PKR 156.96/tablet 542% above median
VIVAX Artesunate 50 mg Tablet 8's 067902 PKR 119.68 PKR 14.96/tablet Near median
VIVAX Artesunate 100 mg Tablet 9's 067917 PKR 209.43 PKR 23.27/tablet Near median
ZOLDI Fluconazole 50 mg Capsule 7'S 052441 PKR 746.45 PKR 106.64/capsule 15% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Allmed (Pvt.) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/allmed-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.